Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Yutaka, Shimazu"'
Autor:
Yutaka Shimazu, Junya Kanda, Satoru Kosugi, Tomoki Ito, Hitomi Kaneko, Kazunori Imada, Yuji Shimura, Shin-ichi Fuchida, Kentaro Fukushima, Hirokazu Tanaka, Satoshi Yoshihara, Kensuke Ohta, Nobuhiko Uoshima, Hideo Yagi, Hirohiko Shibayama, Ryosuke Yamamura, Yasuhiro Tanaka, Hitoji Uchiyama, Yoshiyuki Onda, Yoko Adachi, Hitoshi Hanamoto, Ryoichi Takahashi, Mitsuhiro Matsuda, Takashi Miyoshi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Novel therapeutic drugs have dramatically improved the overall survival of patients with multiple myeloma. We sought to identify the characteristics of patients likely to exhibit a durable response to one such drug, elotuzumab, by analyzing
Externí odkaz:
https://doaj.org/article/f9f360c7a7b8496ea74ce32ada6c5c4d
Autor:
Yutaka Shimazu, Junya Kanda, Hitomi Kaneko, Kazunori Imada, Ryosuke Yamamura, Satoru Kosugi, Yuji Shimura, Tomoki Ito, Shin-ichi Fuchida, Hitoji Uchiyama, Kentaro Fukushima, Satoshi Yoshihara, Hitoshi Hanamoto, Hirokazu Tanaka, Nobuhiko Uoshima, Kensuke Ohta, Hideo Yagi, Hirohiko Shibayama, Yoshiyuki Onda, Yasuhiro Tanaka, Yoko Adachi, Mitsuhiro Matsuda, Masato Iida, Takashi Miyoshi, Toshimitsu Matsui, Ryoichi Takahashi, Teruhito Takakuwa, Masayuki Hino, Naoki Hosen, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Daratumumab is one of the most widely used treatments for relapsed/refractory multiple myeloma (MM) patients. However, not all patients achieve a lasting therapeutic response with daratumumab. Objectives: We hypothesized that a durable re
Externí odkaz:
https://doaj.org/article/de0e47159d65497ba083e4d809b5a35a
Autor:
Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko, Yuji Shimura, Shin-ichi Fuchida, Aya Nakaya, Tomoki Itou, Ryosuke Yamamura, Hirokazu Tanaka, Hirohiko Shibayama, Yutaka Shimazu, Hitoji Uchiyama, Satoshi Yoshihara, Yoko Adachi, Mitsuhiro Matsuda, Hitoshi Hanamoto, Nobuhiko Uoshima, Satoru Kosugi, Kensuke Ohta, Hideo Yagi, Yuzuru Kanakura, Itaru Matsumura, Masayuki Hino, Shosaku Nomura, Chihiro Shimazaki, Akifumi Takaori-Kondo, Junya Kuroda
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
Background: Little is known about the real-world survival benefits and safety profiles of carfilzomib–lenalidomide–dexamethasone (KRd) and carfilzomib–dexamethasone (Kd). Methods: We performed a retrospective analysis to evaluate their efficacy
Externí odkaz:
https://doaj.org/article/c8a169335f1a487791719eaf9c1c6082
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 1054-1055 (2022)
Externí odkaz:
https://doaj.org/article/5ac62fd3450544c7ba2d3a7c3beadc2c
Autor:
Yutaka Shimazu, Junya Kanda
Publikováno v:
eJHaem, Vol 2, Iss 2, Pp 291-292 (2021)
Externí odkaz:
https://doaj.org/article/d175a8e6bc4442eba4332098f18f03a1
Autor:
Hisashi Ishida, Hiroyuki Shimada, Akihiko Tanizawa, Yutaka Shimazu, Takayoshi Tachibana, Noriko Doki, Takahide Ara, Yayoi Matsuo, Miho Nara, Tomomi Toubai, Kazuko Ino, Hirohisa Nakamae, Keisuke Kato, Koji Kato, Atsushi Sato, Moeko Hino, Kimikazu Matsumoto, Yoshiko Atsuta, Masahiro Yasui, Tokiko Nagamura‐Inoue
Publikováno v:
American Journal of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82a5d04ed055f1457cb70143e6e03dc3
https://doi.org/10.1002/ajh.26959
https://doi.org/10.1002/ajh.26959
Autor:
Yutaka Shimazu, Chisaki Mizumoto, Kazuhisa Chonabayashi, Yuta Hanyu, Junya Kanda, Akifumi Takaori-Kondo
Publikováno v:
Annals of Hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a79e2307acb642c3466a3515221ae28
https://doi.org/10.1007/s00277-023-05215-4
https://doi.org/10.1007/s00277-023-05215-4
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a98c231feb731d0054fdf92517714d
https://doi.org/10.1158/2326-6066.22537238
https://doi.org/10.1158/2326-6066.22537238
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Supplementary Figure S1. Sorting strategy of primary ATL cells, Supplementary Figure S2. Methylation status of CTLA4 exon 2 and HELIOS intron 5, Supplementary Figure S3. Hypomethylation of the TSDR correlates with FOXP3 expression, Supplementary Figu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed3568ddbf88bc17a0ae6ac02f55921
https://doi.org/10.1158/2326-6066.22537235
https://doi.org/10.1158/2326-6066.22537235
Autor:
Akifumi Takaori-Kondo, Shimon Sakaguchi, Hiroyoshi Nishikawa, Norimitsu Kadowaki, Masahiro Kawahara, Sumie Fujii, Noriko Sugino, Yuya Nagai, Masahide Hamaguchi, Masakatsu Hishizawa, Yutaka Shimazu, Yayoi Shimazu
Supplementary Table S3. Female Patients' characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60a3d6955238ab9d699421effb181b7e
https://doi.org/10.1158/2326-6066.22537223.v1
https://doi.org/10.1158/2326-6066.22537223.v1